MagedKhalilMD

Oncology • Allentown, PA

Hematologist Oncologist at Lehigh Valley Hospital

Join to view full profile

Dr. Khalil is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Khalil's full profile

Already have an account?

Office
1240 S Cedar Crest Blvd
Ste 103
Allentown, PA 18103
Phone+1 610-402-7880

Fax+1 610-402-7881
Is this information wrong?

Education & Training

One Brooklyn Health System/Brookdale University Hospital and Medical CenterFellowship, Hematology and Medical Oncology, 2004 - 2007
One Brooklyn Health System/Brookdale University Hospital and Medical CenterResidency, Internal Medicine, 2000 - 2003
Cairo University School of MedicineClass of 1999

Certifications & Licensure

PA State Medical License 2007 - 2024
NY State Medical License 2003 - 2013
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Patient-Centered Specialty Practice Recognition Program National Committee for Quality Assurance, 2014-2017
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012

Clinical Trials

Home-Based Programs for Improving Sleep in Cancer Survivors Start of enrollment: 2010 Apr 01
Terminated
Phase 2
Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery Start of enrollment: 2009 Oct 28
Completed
Phase 3
S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery Start of enrollment: 2011 Apr 01
Active, not recruiting
Phase 3
A Study of Nivolumab Plus Ipilimumab, Ipilimumab Alone, or Cabazitaxel in Men With Metastatic Castration-Resistant Prostate Cancer (CheckMate 650) Start of enrollment: 2017 Mar 26
Active, not recruiting
Phase 2
A Study of Nivolumab Plus Bempegaldesleukin (Bempeg/NKTR-214) vs Nivolumab Alone vs Standard of Care in Participants With Bladder Cancer That May Have Invaded The Muscle Wall of the Bladder and Who Cannot Get Cisplatin, A Type of Medicine Given To Treat Bladder Cancer Start of enrollment: 2020 Feb 05
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

25 citations
Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial.
Samuel A Funt, Michael Lattanzi, Karissa Whiting, Hikmat Al-Ahmadie, Colleen Quinlan, Min Yuen Teo, Chung-Han Lee, David Aggen, Danielle Zimmerman, Deaglan McHugh, Arl...> ;Journal of Clinical Oncology. 2022 Apr 20
3 citations
Neoadjuvant Immunotherapy in Microsatellite-Instability High Nonmetastatic Colorectal Cancer: A Single-institute Experience and Review of the Literature.
Rachel E Kinney, Maged F. Khalil> ;Clinical Colorectal Cancer. 2021 Jun 1
13 citations
Induction versus no induction chemotherapy before neoadjuvant chemoradiotherapy and surgery in oesophageal adenocarcinoma: a multicentre randomised phase II trial (NCC...
Harry H. Yoon, Fang-Shu Ou, Gamini S. Soori, Qian Shi, Dennis A. Wigle, Robert P. Sticca, Robert C. Miller, James L. Leenstra, Patrick J. Peller, Brenda Ginos, Erica N...> ;European Journal of Cancer. 2021 Jun 1
73 citations
Pembrolizumab in Patients With Metastatic Breast Cancer With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) S...
Ajjai Alva, Pam K. Mangat, Elizabeth Garrett-Mayer, Susan Halabi, Damien Hansra, Carmen Julia Calfa, Maged F. Khalil, Eugene R Ahn, Timothy L. Cannon, Pamela A. Crille...> ;Journal of Clinical Oncology. 2021 Apr 12
5 citations
PIVOT-10: Phase II study of bempegaldesleukin plus nivolumab in cisplatin-ineligible advanced urothelial cancer.
Robert Huddart, Arlene O. Siefker-Radtke, Arjun Vasant Balar, Mehmet Asim Bilen, Thomas Powles, Aristotelis Bamias, Daniel Castellano, Maged F. Khalil, Michiel S. van ...> ;Future Oncology. 2021 Jan 1
5 citations
Investigating the prognostic value of KOC (K homology domain containing protein overexpressed in cancer) overexpression after curative intent resection of pancreatic d...
Benny Johnson, Maged F. Khalil, Joseph Blansfield, Fan Lin, Shaobo Zhu, H. Lester Kirchner, Alva B. Weir> ;Journal of Gastrointestinal Oncology. 2016 Dec 1
1 citations
Hepatocellular carcinoma in an African American man with a noncirrhotic liver presented initially as an occipital mass.
Maged Khalil, Padjama Sai, Zili He, Ashraf Aziz, William Steier, Shetra Sivamurthy, Ming Liu, Madhumati Kalavar> ;Clinical Advances in Hematology & Oncology. 2005 Jul 1
23 citations
Epithelioid Angiosarcoma of the Small Intestine After Occupational Exposure to Radiation and Polyvinyl Chloride: A case Report and Review of Literature.
Maged F. Khalil, Asha Thomas, Adel Aassad, Moshe Rubin, Robert N. Taub> ;Sarcoma. 2005 Jan 1
68 citations
Molecular Interactions Leading to Lipoprotein Retention and the Initiation of Atherosclerosis
Maged F. Khalil, William D. Wagner, Ira J. Goldberg> ;Arteriosclerosis, Thrombosis, and Vascular Biology. 2004 Dec 1
Join now to see all

Hospital Affiliations

Lehigh Valley Hospital-Cedar CrestAllentown, Pennsylvania
Lehigh Valley Health Network - MuhlenbergBethlehem, Pennsylvania